Skip to content

Study on Urinary Sodium-to-Potassium Ratio by Using Potassium-Enriched Salt Substitutes for Older Adults

Effect of potassium-enriched salt substitutes on reducing single casual spot urine sodium-to-potassium ratio in older adults

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1020260019
Enrollment
46
Registered
2026-06-23
Start date
2025-07-22
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Community-dwelling older adults who meet the eligibility criteria in this study

Interventions

We will conduct a 2-week intervention in which participants replace their usual seasonings (soy sauce, miso, and salt) that do not contain added potassium for salt reduction with the distributed potas

Sponsors

Shimooki Osamu
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Select individuals who fulfill all of the following conditions as research subjects. (1) The elderly aged 65 and older. (2) A household consisting only of individuals aged 65 and older. (3) Individuals who have a habit of eating two or more home-prepared meals per day, including packed lunches. (4) Individuals capable of answering the survey independently. (5) All household members have consented to participate in this study.

Exclusion criteria

Exclusion criteria: Subjects meeting any of the following criteria will be excluded from the study. (1) Cases where the applicant or any member of their household meets any of the following conditions: Being restricted from potassium intake by a doctor Having poor kidney function Having an allergy to the seasonings, milk, or dairy products used in this study Having severe physical symptoms that make it difficult to participate in this study (2) Having used a potassium-enriched salt substitute (Product name: Soy sauce: Iwate Kenmin (Manufacturer: Asanuma Soy sauce Shop Co., Ltd), Miso: Nyusei MINERAL Kouji MISO (Manufacturer: TAKEYA MISO Co., Ltd), Salt: Herushioraito (Manufacturer: Enyu Shouji Co., Ltd) within 2 weeks prior to the pre-intervention examination (3) Having a serum potassium level over 4.8 mmol/L or an eGFR under 45 mL/min/1.73 m2 in the pre-intervention examination. (4) Suspected of having pseudohyperkalemia in the pre-intervention examination

Design outcomes

Primary

MeasureTime frame
Presence or absence of a decrease in post-intervention single casual spot urine sodium-to-potassium ratio

Secondary

MeasureTime frame
(1) Changes in blood pressure and serum potassium levels after the intervention compared to before the intervention. (2) Association between the presence of post-intervention hyperkalemia and pre-intervention data. (3) Presence or absence of changes in physical condition or occurrence of health hazards during the intervention period.

Contacts

Public ContactTomohiro Takahashi

Iwate Medical University

ttakahas@iwate-med.ac.jp+81-19-651-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026